RxDoctor Payments Data

Luis Natali, MD

Neurology · Mayaguez, PRNPI 1578709440

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 340 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 40 manufacturers reported payments, led by AbbVie at 35.4% of the total.

$4,944in general payments, 2019–2025

Across 340 payments — averaging $14.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novartis$563
  • Lilly USA, LLC$307
  • SK Life Science, Inc.$301
  • Teva Pharmaceuticals USA, Inc.$213
  • Biogen$196
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$4,944100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,944 in reported general payments places this provider in the 75th percentile of 129 neurology providers in Puerto Rico.

See all neurology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$183,457
Medicare patients
457
Services billed
1,507

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin148$1,712
Pregabalin25$1,345
Levetiracetam28$1,312
Donepezil Hcl117$1,232
Carbidopa-LevodopaCarbidopa/Levodopa44$1,009
Memantine Hcl46$968
Tizanidine Hcl108$569
Lamotrigine29$439
Citalopram HbrCitalopram Hydrobromide64$281
ClopidogrelClopidogrel Bisulfate25$261
Primidone25$216
Baclofen33$204
Meloxicam88$107
Quetiapine Fumarate26$73

Paid to pharmacies, not to this prescriber.

Other neurology in Mayaguez

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →